Clinical trial
Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)
NCT04728295 is registered in ClinicalTrials.gov with InSightec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)
- Lead sponsor
- InSightec
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 14, 2021
- Completion date
- December 1, 2028
- Enrollment
- 50 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.